In our studies, we generated and characterized HER2-VEGFA BsAbs to enable co-phagocytosis of VEGFA with HER2-overexpressing cancer cells through simultaneous binding to HER2 and VEGFA. The gene discussed is VEGFA; the disease is cancer.